Pfizer reveals AstraZeneca bid

US drugs giant Pfizer today publicly disclosed details of a multi-billion pound bid approach for UK rival AstraZeneca.
The American firm revealed it had been rebuffed by Astra after initial talks in January valuing the company at £58.7 billion, and added that further overtures this weekend were also rejected.